Development and testing of a decision aid for lung cancer screening in smokers
Promoting Informed Decisions About Lung Cancer Screening: Decision Aid Update and Measures Development
This study is trying out a new tool to help heavy smokers understand their options for lung cancer screening and see if they find it helpful.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 620 (estimated) |
| Ages | 55 Years to 80 Years |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 2 sites (Galveston, Texas and 1 other locations) |
| Trial ID | NCT02282969 on ClinicalTrials.gov |
What this trial studies
This project aims to help heavy smokers make informed decisions about lung cancer screening using low-dose computed tomography (CT). In the initial phase, a prototype decision aid will be updated to align with current screening guidelines and will undergo cognitive testing with participants. The updated aid will then be pilot-tested for acceptability among smokers. Participants will engage in interviews and complete questionnaires to assess their knowledge and attitudes towards lung cancer screening.
Who should consider this trial
Good fit: Ideal candidates for this study are men and women aged 55 to 80 who are current smokers or have quit smoking within the past 15 years.
Not a fit: Patients with a history of lung cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could empower smokers to make better-informed decisions regarding lung cancer screening, potentially leading to earlier detection and improved outcomes.
How similar studies have performed: Other studies have shown success in using decision aids for cancer screening, indicating that this approach is promising and not entirely novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Men and women 55 to 80 years of age. 2. Participants must speak English. 3. Current smoker or quit smoking within the past 15 years. Exclusion Criteria: 1\. History of lung cancer.
Where this trial is running
Galveston, Texas and 1 other locations
- The University of Texas Medical Branch at Galveston — Galveston, Texas, United States (Recruiting)
- University of Texas MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Suzanne Linder, PHD — The University of Texas Medical Branch at Galveston
- Study coordinator: Robert Volk, PHD
- Email: BVolk@mdanderson.org
- Phone: 713-563-2509
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.